Rx for Africa, Inc.

Investing in Generic Pharmaceutical Manufacturing in Sub-Saharan Africa

ANNOUNCEMENT: Replay of conference calls available here.

Rx for Africa, Inc. a public New Jersey corporation, was formed in 2007 to invest in companies manufacturing generic pharmaceuticals in Sub-Saharan Africa. Most pharmaceuticals marketed in Africa are imported. We believe the time is right for in-country facilities that conform to good manufacturing practice (GMP) and we believe these companies can be run profitably while benefiting the local economies by creating jobs at all levels, including professional class (scientists, plant managers, accounting staff). Our wholly-owned Ethiopian operating company has hired scientists from India and Germany to staff its newly completed R&D Center, and is currently manufacturing a list of generic pharmaceuticals. Everything they manufacture is sold.